The FDA’s “Project Optimus” and Oncology Drugs
Julie Bullock, VP, Global Head of Clinical Pharmacology and Translational Medicine at Certara discusses the FDA's Oncology Center of Excellence's new in...
295 articles
Julie Bullock, VP, Global Head of Clinical Pharmacology and Translational Medicine at Certara discusses the FDA's Oncology Center of Excellence's new in...
President Biden recently announced a multi-faceted cancer pledge with the goal of reducing mortality from the disease by 50 percent during the next 25 y...
Liz Homans, CEO of Lyell Immunopharma, discusses how the company is tackling one of the hottest topics in cancer treatment: how to deploy cell therapy t...
Jean-Francois Boileau, MD, MSc, FRCSC, surgical oncologist at Jewish General Hospital Segal Cancer Centre; associate professor of surgery and oncology...
Vivek Subbiah, MD, Associate Professor in the Investigational Cancer Therapeutics department and Center Clinical Medical Director of the Clinical Center...
Screening and earlier detection are key in the fight against cancer. Learn more on Health Professional Radio.
Corey Lawson, Vice President of Product Strategy at Accuray, a company that develops unique market-changing radiotherapy solutions, discusses the fast c...
Marilyn C, stage 4 lung cancer survivor discusses her treatment journey with immunotherapy, how she dealt with the stigma and misinformation associat...
Lisa Barroilhet, Associate Professor in the department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health ...
Ronald Martell, President and CEO at MorphImmune discusses MorphImmune's proprietary platform that enables reprogramming or removal of aberrant cells wi...